Search for: "Barr v. State"
Results 761 - 780
of 939
Sorted by Relevance
|
Sort by Date
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
17 Dec 2007, 7:17 am
Partnerships are strong, with paid families working with Title V/CSHCN, the Medicaid agency, and the University of Vermont College of Medicine. [read post]
27 Nov 2023, 6:00 pm
State Rifle & Pistol Ass'n v. [read post]
28 Jul 2023, 11:49 am
Barr ,1 illustrates the problem. [read post]
1 Dec 2019, 7:09 am
That he has gotten away with this for such a long time is all the more astounding considering that his boss, Attorney General William Barr, once testified against Qualcomm and its business practices.As I just said, each of those many pro-FTC submissions serves a purpose. [read post]
27 Mar 2020, 10:16 am
Attorney General William Barr requesting information concerning the Department of Justice’s (DOJ) handling of the Coronavirus Pandemic and the health and safety of both (1) those imprisoned and (2) those working in federal prisons. [read post]
25 Jun 2024, 1:29 pm
United States v. [read post]
26 Nov 2023, 7:06 am
To be sure, in a series of cases staring with the Delaware Supreme Court’s 2019 decision in Marchand v. [read post]
29 Sep 2009, 11:38 am
We noted in Cross v. [read post]
18 Oct 2019, 12:56 pm
Finally, in Lomax v. [read post]
8 Nov 2021, 12:25 pm
Barr, No. 19-cv-1581, 2019 WL 2870234, at *2 (D.D.C. [read post]
27 May 2008, 6:41 am
Barr Labs., Inc., 251 F.3d 955, 963 (Fed. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
7 Jun 2010, 9:36 am
Related posts:Prosecution Laches and Inequitable Conduct: Cancer Research Tech. v Barr Labs. [read post]
8 Dec 2010, 10:42 am
Inc. v. [read post]
30 Jul 2023, 11:24 am
See United States v. [read post]
23 May 2019, 7:08 am
The analysis is lengthy, so I will state my main conclusions here: None of the critics defends the report’s actual reasoning, which is pretty obviously flawed. [read post]
7 Apr 2019, 6:45 am
In May 2017, the Ninth Circuit Court of Appeals in United States v. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
6 Mar 2020, 6:00 am
Though the committee cites the Supreme Court’s decision in Arizona State Legislature v. [read post]
